CSMF
AMGN icon

Charles Stewart Mott Foundation’s Amgen AMGN Stock Holding History

Charles Stewart Mott Foundation’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,177
Closed -$439K – 10
2015
Q3 		$439K Buy
+3,177
New +$501K 0.49% 37

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Charles Stewart Mott Foundation's AMGN Position: Q4 2015 in Review

Charles Stewart Mott Foundation sold out of Amgen (AMGN) in Q4 2015, closing a stake of 3,177 shares — an estimated $439K sold.

Charles Stewart Mott Foundation first reported a position in AMGN in Q3 2015 and held it in 1 quarter. The position peaked at $439K in Q3 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Charles Stewart Mott Foundation reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • Charles Stewart Mott Foundation sold 3,177 Amgen shares in Q4 2015, an estimated $439K.
  • Charles Stewart Mott Foundation first reported a position in Amgen in Q3 2015 and held it in 1 quarter.
  • Charles Stewart Mott Foundation's Amgen position peaked at $439K in Q3 2015.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Charles Stewart Mott Foundation's 13F filing for Q4 2015, filed 16 Feb 2016.